Previous Article | Next Article ![]()
Journal of Bacteriology, October 2006, p. 6824-6831, Vol. 188, No. 19
0021-9193/06/$08.00+0 doi:10.1128/JB.00567-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
nutL by HK022 Nun Protein
Department of Microbiology and Institute of Cancer Research, Columbia University Medical Center, New York, New York 10032,1 Molecular Control and Genetics Section, Gene Regulation and Chromosome Biology, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702-12022
Received 21 April 2006/ Accepted 14 July 2006
| ABSTRACT |
|---|
|
|
|---|
by binding nascent
pL and pR transcripts at nutL and nutR, respectively, and inducing transcription termination just downstream of these sites. Termination is more efficient at nutL than at nutR. One difference between nutL and nutR is the presence of RNase III processing sites (rIII) located immediately promoter distal to
nutL. We found that deletion of rIII dramatically reduced Nun transcription arrest in vitro but had little effect on termination in vivo. However, consistent with the in vitro results, overexpression of a transcript carrying nutL and rIII efficiently titrated Nun, allowing
to grow on a strain that expressed Nun, whereas a transcript carrying only nutL or nutL-rIII with nucleotides 97 to 141 deleted was ineffective. Rnc70, an RNase III mutant that binds but does not cleave rIII, also prevented Nun-mediated
exclusion. We propose that rIII enhances the on-rate of Nun at nutL, stimulating Nun-mediated arrest in vitro. We have shown that a specific element in rIII, i.e., box C (G89GUGUGUG), strongly enhances arrest on rIII+ templates. Nun-rIII interactions do not stimulate Nun termination in vivo, presumably because formation of the Nun-nutL complex is normally not rate-limiting in the cell. In contrast to Nun, N is not occluded by Rnc70 and is not efficiently titrated by a nutL-rIII transcript. | INTRODUCTION |
|---|
|
|
|---|
RNA at nutL and nutR, inducing transcription termination at various points distal to these sites. Nun expressed from HK022 prophage thus excludes superinfecting
(17). Host factors involved in Nun-dependent termination are identical to those for
N-mediated antitermination (18). Both reactions are abrogated by certain mutations in nusA, nusB, nusE (S10), and nusG. In vitro, Nun inhibits transcription elongation but does not release the arrested transcription elongation complex (TEC). Nun activity in vitro requires a TEC that includes nascent nutL or nutR; Nus factors are not absolutely required but enhance the in vitro efficiency of Nun-mediated arrest (7).
The
nutL and nutR sites are composed of three conserved motifs, including box A (8 nucleotides [nt]), box B (15 nt), and box C (8 nt) (Fig. 1). Box A RNA recruits NusB and NusE into a
N antitermination complex that includes RNA polymerase (RNAP), NusA, and NusG (15, 16). Box B RNA forms a stem-loop that binds
N or HK022 Nun and, subsequently, NusA (2, 6, 8, 27). Box B RNA alone binds
N and Nun with similar affinities. This equivalent affinity for box B RNA does not reflect the inability of
N to compete with Nun at nutL in vivo. A third conserved motif, box C (8 nt) (Fig. 1), lies downstream of nutL and nutR and does not appear to play a role in
antitermination (5). The two nut sites differ in the spacer regions between box A, box B, and box C and by a single nt change in the box B loop and the sixth nt in box C.
|
pL, whereas nutR lies 227 nt from its cognate promoter. True termination of Nun-arrested TEC requires host Mfd protein, a DNA helicase that recognizes and dissociates stalled RNAP. Mfd appears to act at nutR but not at nutL, possibly because the short distance between pL and nutL precludes Mfd access. Thus, the off-rate of Nun-TEC complexes is lower at nutL than at nutR (26).
nutL also differs from nutR in that it lies immediately promoter proximal to RNase III cleavage sites (rIII) (Fig. 1). Nascent pL transcripts are cleaved at nt 71, 88, and 197, whereas the mature transcript is cleaved at nt 88 and 197 (13). This suggests that rIII forms transient RNase III substrate structures (Fig. 1B and C) prior to formation of a more stable structure (9) (Fig. 1A).
Cleavage at rIII prevents repression of
N translation by N or Nun bound at nutL (4, 10). Isolation of rIII mutants resistant to Nun inhibition of N translation (nun3 and nun1) (Fig. 1) suggested that Nun might make contacts with rIII. We present evidence showing that a part of rIII does in fact interact with Nun and that this interaction enhances Nun activity in vitro but not in vivo.
| MATERIALS AND METHODS |
|---|
|
|
|---|
W336,
W335, pL-nutL-rIII
97-106, pL-nutL-rIII
76-140, and pL-nutL-rIII
141-209, which were amplified by PCR using the DNA oligonucleotides 5'-CCGCTCGAGAGGTGACGCTCTTAAAAAT-3' and 5'-CCGCTCGAGCCATCTGGATTCTCCTG-3' and cloned into the XhoI site of pRSW101.
|
ß-Galactosidase assays. Strains were grown in LB at 32°C with shaking to an optical density at 600 nm of 0.1 and then shifted to 42°C and grown to an optical density at 600 nm of 0.6. Where indicated, the appropriate antibiotic (100 µg/ml ampicillin or 50 µg/ml kanamycin) was present. Nun, when expressed from a plasmid under the control of the pBAD promoter, was induced by the addition of 0.05% arabinose. Cells were assayed for ß-galactosidase activity as described by Miller (14).
Templates for in vitro transcription.
DNA templates were generated by PCR, using AmpliTaq DNA polymerase (Roche Diagnostics, Branchburg, NJ) and DNA oligonucleotides (5'-GGAATTCCATATGTCAGATCTCTCACCTACCAAAC-3' and 5'-AGGGCGGTTAACTGGTTTTG-3') to amplify a 500-bp fragment of phage
including pL-nutL-rIII. A pL-nutL-
rIII fragment was prepared by using genomic DNA from
W336 as the template. The remaining mutant templates were produced as follows: the 5' ends of pL-nutL-rIII
76-141 (5'-CCGTGATCACAATGTGCCAATCGC-3') and pL-nutL-rIIIboxCmut (5'-CCGTGATCAGCAGAAGGCTTTGCCCACACACATACGAAACGAAGC) were amplified using the indicated DNA oligonucleotides paired with the oligonucleotide 5'-GGAATTCCATATGTCAGATCTCTCACCTACCAAAC-3', digested with BclI, and ligated to the 3' fragment of pL-nutL produced with the oligonucleotides 5'-AGGGCGGTTAACTGGTTTTG-3' and 5'-CGGGATCCTTTGAATGCTGCCC-3' and digested with BamHI. pL-nutL-rIII
141-209 (5'-CCGTGATCAACAGGAGAATCCAGATG-3') was amplified using the indicated DNA oligonucleotide paired with 5'-GGAATTCCATATGTCAGATCTCTCACCTACCAAAC-3', digested with BclI, and ligated to the 3' fragment of pL-nutL produced with the oligonucleotides 5'-AGGGCGGTTAACTGGTTTTG-3' and 5'-CGGGATCCGCAGCTAATCCGGAATC-3' and digested with BamHI. pL-nutL-rIII
97-186 (5'-CCGTGATCACACACACCACCAAAG-3') was amplified using the indicated DNA oligonucleotide paired with 5'-GGAATTCCATATGTCAGATCTCTCACCTACCAAAC-3', digested with BclI, and ligated to the 3' fragment of pL-nutL produced with the oligonucleotides 5'-AGGGCGGTTAACTGGTTTTG-3' and 5'-CGGGATCCCACACACCCCAAAGC-3' and digested with BamHI. pL-nutL-rIIIG114A, T117A, G122A, G125A was amplified using the DNA oligonucleotides 5'-CCGTGATCATACGAAACGAAGCATTGGCCG-3' and 5'-GGAATTCCATATGTCAGATCTCTCACCTACCAAAC-3', digested with BclI, and ligated to the 3' fragment of pL-nutL produced with the oligonucleotides 5'-AGGGCGGTTAACTGGTTTTG-3' and 5'-CGGGATCCGCAGCTAATCCGGAATTGCATTTACTGCTAATGCTTCG -3' and digested with BamHI.
In vitro termination assay.
Open complexes were formed by preincubating 0.1 pmol template bound with 0.5 units RNAP (Epicenter) in 50 µl TB (20 mM Tris-acetate [pH 7.9], 60 mM potassium acetate, 4 mM magnesium acetate, 1 mm dithiothreitol, 0.25 mg/ml bovine serum albumin, and 5% glycerol) for 5 min at 32°C. The Nun protein, when included, was added at the indicated concentration (1.25, 2.5, or 5 pmol/reaction). Transcription was initiated by the addition of a 10 µM concentration of each nucleoside triphosphate plus 1 µCi [
-32P]ATP. After incubation at 32°C for 5 min, the reactions were terminated by the addition of 50 µl stop solution (375 mM sodium acetate [pH 5.2] and 62.5 mM EDTA). The reaction mixtures were extracted with an equal volume of phenol-chloroform-isoamylalcohol (Sigma) and ethanol precipitated with 3 volumes of 95% ethanol. Extracted RNAs were then resolved in a denaturing 12% polyacrylamide gel and analyzed by autoradiography.
Readthrough transcription was measured by excising the appropriate gel bands and measuring radioactivity in a liquid scintillation counter.
Efficiency of
plating.
Bacteria (
109 cells) of the appropriate strains were poured in top agar on LB or LB plus 50 µg/ml kanamycin plus 100 µg/ml ampicillin to produce lawns. IPTG (isopropyl-ß-D-thiogalactopyranoside; 0.1 mM) was added to induce transcription of nutL or nutL-rIII from pRSW110-114. Efficiencies of plating were determined by spotting dilutions of
phage on the bacterial lawns before incubating them overnight at 37°C.
| RESULTS |
|---|
|
|
|---|
pL-nutL-rIII template and the same template containing mutations within rIII (Fig. 1). The efficiency of arrest is indicated by the decrease in transcriptional readthrough induced by Nun. The presence of rIII clearly enhanced Nun activity (Fig. 2A). At 100 nM, Nun allowed only 30% readthrough on the rIII+ template, compared to 68% readthrough on the
rIII template (Fig. 2A, lanes 4 and 16). Reducing readthrough on the
rIII template to levels comparable to those with the wild-type template required 400 nM Nun (data not shown). Deleting the 5' end of rIII (
76-141) was equivalent to deleting the entire rIII site (lanes 5 to 8), as was deleting the loop region (
97-186; lanes 9 to 12). Deleting sequences 3' of nt 140 (
141-209) did not affect arrest (lanes 17 to 20).
|
rIII template that lie between nt 97 and 141. We then examined the contributions made by the predominant Nun arrest sites, G114, T117, G122, and G125 (3). Figure 2B, lanes 1 to 4, shows Nun arrest on a nutL template with an A substitution at each site. The quadruple mutant template was less efficient for arrest than the rIII+ template (50% versus 30% readthrough) (Fig. 2A and B, lanes 1 to 4). The pattern of arrest was also changed: arrest was distributed over several sites 3' of nt 122. These data confirm that rIII+ nt 114, 117, 122, and 125 contribute significantly to Nun arrest in vitro.
We then asked if box C (G89GUGUGUG), a conserved sequence on the ascending arm of rIII, enhanced the efficiency of Nun arrest (5). We constructed a template, boxCmut, which contains the complement of box C (C89CACACAC). Figure 2B, lanes 5 to 8, shows the results of a transcription assay with this template. Nun arrest was dramatically reduced compared to that with the rIII+ template (69% versus 30% readthrough) and was equivalent to the efficiency of Nun arrest on the rIII
76-209 template (68%) (Fig. 2A, lanes 13 to 16). The boxCmut template has two strong Nun-independent spontaneous pauses introduced in the region of nt 89 to 96 (Fig. 2B, lane 5). Our interpretation of these results is that box C enhances arrest at G114, T117, G122, and G125 but is not sufficient for efficient arrest on templates with these sites deleted or mutated.
Titration of Nun by nutL-rIII transcript in vivo.
Our results suggest that rIII and Nun interact and that these interactions increase Nun arrest efficiency in vitro. We next looked for evidence that Nun and rIII interact in vivo. Accordingly, we compared the abilities of transcripts carrying nutL-rIII or nutL-rIII deletions (
76-209,
141-209,
76-140, and
97-186) to titrate Nun. The transcripts were expressed in a strain expressing a Nun mutant, NunK107A; Nun activity was monitored by
plaque formation (Table 2). Although NunK107A arrests transcription with wild-type efficiency in vitro and in vivo (11), we found it to be titrated more easily than wild-type Nun. We previously showed that transcription of plasmid-borne nutL suppressed Nun exclusion of
, partially in a wild-type host and fully in cells carrying an mfd mutation (26). We suggested that the nutL transcript sequestered and titrated Nun. In confirmation of this result, Nun inhibition of
plating was partially reversed by transcription of nutL-rIII
76-209 from the multicopy plasmid pRSW110 (efficiency of plating [EOP] of <105 [row 2 in Table 2] versus EOP of
102 [row 4]). In contrast, transcription of nutL-rIII from pRSW111 completely restored
plating, even though the host was mfd+ (EOP = 1.0 [Table 2, row 3]). Transcription of nutL-rIII
141-209 restored
plating (EOP = 1.0 [Table 2, row 7]). However,
plated with an EOP of
102 on cells expressing nutL-rIII
76-140 or nutL-rIII
97-186 transcripts (Table 2, rows 5 and 6). Thus, the same region of rIII identified as important for termination in vitro, nt 97 to 141, was found to titrate NunK107A in vivo. Alternatively, the sequences from nt 97 to 141 could be important for increasing the in vivo stability of the nutL RNA.
|
plating on HK022 lysogens (Table 3). Overexpression of Rnc+ had no effect on
plating, whereas Rnc70 overexpression completely suppressed Nun exclusion (Table 3, rows 4 to 6). Rnc70 failed to protect
rIII from exclusion by Nun (data not shown).
|
|
|
76-209 fusion (Table 4, row 8) might thus be explained. Our results support the ideas that Nun recognizes rIII and that Rnc70 competes with Nun for this interaction. The failure of wild-type RNase III to suppress Nun might be explained by a lower affinity for partially transcribed rIII.
Effect of rIII on Nun termination in vivo.
We then examined the contribution of rIII to Nun termination in strains N9482 and N9483 (Table 1). These strains carry the chromosomal N::lacZ transcription fusions
pL-nutL-rIII-N::lacZ and
pL-nutL-N::lacZ, respectively. Plasmid-borne NunK107A was expressed from the pBAD promoter. Nun concentrations were increased over basal levels, where indicated, by induction of pBAD with 0.05% arabinose.
Nun efficiently terminated transcription on the rIII+ fusion (N9482). ß-Galactosidase activity was reduced to 3% that of a control strain without the NunK107A plasmid. Induction of Nun expression with arabinose further reduced the ß-galactosidase activity to 0.6% that of the control (Table 5, rows 1 to 3). Nun-mediated termination was almost as efficient in fusions lacking rIII. At basal levels of Nun, ß-galactosidase activity was 6.5% that of the control. Nun overexpression reduced the ß-galactosidase activity to 1.3% that of the control (Table 5, rows 4 to 6). These results indicate that deletion of rIII decreases the in vivo Nun termination efficiency at nutL twofold, at most. We concluded that Nun interactions with rIII contribute to but are not essential for termination in vivo.
|
nascent transcript.
rIII and
N antitermination in the pL operon.
We next asked if rIII affected the ability of
N to antiterminate at nutL. The
red and gam genes lie downstream of terminators in the pL operon (19). Although the products of these genes are not essential for
growth in recA+ hosts, they are absolutely required in a recA-negative background. Table 6 confirms that antitermination is needed for
plaque formation on a recA56 host. Thus,
plates with an EOP of 1.0 on recA56, whereas
nutL400, which carries a mutation in box B that eliminates N antitermination (19), fails to grow (EOP, <105). In contrast,
rIII, which carries a precise deletion of rIII, plates with an EOP of 1.0. We concluded that deletion of rIII does not ablate N antitermination at nutL. Table 6 also shows that Rnc70 overexpression, which inhibits Nun termination, does not reduce
plating on a recA56 host or the plating of a control phage,
rIII, which does not bind RNase III.
Finally, we found that overproduction of a nutL-rIII transcript did not titrate N. Thus,
and
r32, a mutant that fails to grow when N is limiting, plated with an EOP of 1.0 on both RSW237, which overexpresses nutL, and RSW238, which overexpresses nutL-rIII (data not shown).
| DISCUSSION |
|---|
|
|
|---|
pL and pR operons is antiterminated by
N or prematurely terminated by phage HK022 Nun. Both the N and Nun proteins recognize box B RNA sequences of nutL and nutR and act in complex with four host Nus proteins to modify the TEC. Phage
fails to grow on an HK022 lysogen because Nun both competes with N to prevent antitermination and directly causes transcription termination distal to the nut sites (2, 7). The nut region is also subject to another form of regulation. Translation of N, the first gene in the pL operon, is partially depressed by the rIII secondary structure and strongly inhibited by the N antitermination or Nun termination complex at nutL (Fig. 1) (10, 27). The rIII structure and the N or Nun complex at nutL are thought to interfere with ribosomal attachment to the adjacent N ribosome-binding site (Fig. 1A). In this work, we asked if rIII also plays a role in Nun termination. We provide evidence that Nun and rIII interact in vitro and in vivo. An rIII site on a template significantly enhanced Nun-dependent transcription arrest at nutL in vitro. Two elements in rIII contribute to the increased efficiency of Nun, namely, box C and four major arrest sites (nt 114, 117, 122, and 125). We propose that box C provides a recognition element for Nun that stimulates arrest at these sites.
In vivo titration assays confirmed that Nun binds rIII. Thus, overproduction of a transcript that included nutL-rIII permitted
growth on a strain expressing NunK107A. A transcript containing only nutL or nutL-rIII with nt 97 to 141 deleted did not relieve
exclusion. Finally, overexpression of Rnc70, a catalytically inactive RNase III mutant that binds rIII (4), inhibited Nun, presumably by occluding Nun binding to rIII.
However, experiments in vivo with transcriptional fusions linking pL-nutL-rIII or pL-nutL-
rIII and a lacZ reporter revealed, at most, a twofold difference in Nun termination between the two fusions. Our result is consistent with that of Sloan and Weisberg (22), who found that Nun termination was 90% efficient in a pL-nutL-
rIII fusion. We concluded that while rIII contributes to Nun activity at nutL, it does not play a major role under our in vivo assay conditions.
To explain the differences between these in vitro and in vivo results, we propose that the Nun reaction in vitro is rate-limited by the binding of Nun to the
nascent transcript. Nun activity can be measured in a single-round transcription assay. Furthermore, in the absence of Nus factors, the in vitro reaction is suboptimal and requires a large excess of Nun relative to the TEC. In the minimal system described here, therefore, the Nun on-rate is limiting, and Nun binding to the TEC is stimulated by its interaction with rIII. We suggest that under certain, as yet unknown, in vivo conditions, the Nun on-rate might also be limiting, and the binding of Nun to rIII could improve the termination efficiency.
In contrast to deletion of rIII, overproduction of Rnc70, which binds but does not cleave rIII (4), did suppress Nun-dependent termination in a pL-nutL-rIII transcriptional fusion and also restored
plating on an HK022 lysogen. It is plausible that Rnc70 bound to rIII occludes neighboring sequences that are important for Nun activity. Complete occlusion of nutL, however, is ruled out by the observation that N antitermination is resistant to Rnc70.
We found no evidence that rIII affects
N antitermination. Unlike Nun, N is not inhibited by overproduction of the nutL-rIII transcript. Plating of 
rIII on a recA56 host, which requires the pL operon genes red and gam, indicates that rIII is not required for N antitermination in the pL operon. Finally, overproduction of Rnc70 does not prevent
rIII+ propagation on a recA56 host.
These results also shed some light on the failure of N to compete efficiently with Nun at nutL (17). We propose that this is explained, in part, by assuming that Nun recognizes a larger motif than does N at nutL, enhancing its affinity for the pL transcript relative to N. Note that Nun carries 21 amino-terminal amino acids that are lacking in N (24). Whether these residues participate in RNA binding is under investigation. In vitro binding assays with box B RNA did not indicate a difference in affinity between Nun and N (2). It will be interesting to compare the binding of these factors to a larger transcript that includes box C.
Which sequences in the rIII deletion enhance Nun activity in the pL operon? Nun inhibition by Rnc70 indicates that an RNase III binding site is transcribed prior to Nun-mediated termination. Nun termination in vivo forms a series of transcripts within a region 100 nt promoter-distal of nutL (22). Consistent with this result, we (this work and reference 7) found that Nun arrest in vitro occurs predominantly at nt 122. Thus, the RNA sequences recognized by Nun must lie within the proximal 122 nt of the pL operon transcript. Figure 1 shows three possible rIII structures. The structures in Fig. 1B and C are formed transiently and are cleaved by RNase III at nt 71. Figure 1A represents a structure found in the mature pL transcript; this structure is cleaved at nt 88 and nt 197. Our data preclude the structures in Fig. 1A and C, whose endpoints lie beyond the major Nun termination site.
Several candidate sequences lie between nutL and nt 122. First, Nun3, which blocks translation repression by the termination-defective Nun K106/107D protein, is located at nt 67 (11). Two other sequences of potential interest lie in this region of the pL transcript. An inverted repeat, C71AAAGC and G82CUUUG, is found in phages
, 21, and P22 (9). Box C (G89GUGUGUG) is likewise conserved among temperate phages (5). In this work, we found that box C is required in vitro for efficient arrest at nt 114, 117, 122, and 125. This is the first described role for box C in transcription elongation.
rIII promotes translational repression of N by Nun as well as Nun-mediated transcription termination at low concentrations of Nun. This does not explain, however, the higher efficiency of Nun termination at the pL operon than that at the pR operon (99% versus 87%) (12). Some of the difference is due to Mfd, which releases the Nun-arrested TEC at nutR but not nutL (26). Presumably, other factors also play a role in supporting Nun termination at nutL.
| ACKNOWLEDGMENTS |
|---|
This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, and by grant GM37219 from the National Institutes of Health.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
development, p. 22-51. In R. W. Hendrix, J. W. Roberts, F. W. Stahl, and R. A. Weisberg (ed.), The bacteriophage lambda II. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
DNA in vitro and competes with the phage
N antitermination protein. J. Mol. Biol. 247:428-442.[CrossRef][Medline]
N (transcription termination/translation repression). Proc. Natl. Acad. Sci. USA 100:5308-5312.
is made of RNA and is bound by transcription antitermination factors on the surface of RNA polymerase. Genes Dev. 5:2141-2151.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |